Alamdari, S., et al. (2013). "Management of hyperthyroidism in pregnancy: Comparisonof recommendations of american thyroid association and endocrine society." Journal of
Thyroid Research 2013.
Andersen, S. L. (2017). "Risk of embryopathies with use of antithyroidal medications."
Current Opinion in Endocrinology, Diabetes and Obesity 24(5): 364-371.
Azizi, F. and A. Amouzegar (2011). "Management of hyperthyroidism during pregnancy
and lactation." European Journal of Endocrinology, Supplement 164(6): 871-876.
Azizi, F., et al. (2016). "Prevalent practices of thyroid diseases during pregnancy among
endocrinologists, internists and general practitioners." International Journal of
Endocrinology and Metabolism 14(1).
Balon, H. R., et al. (2005). "Reply [7]." Journal of Nuclear Medicine 46(8): 1409.
Bournaud, C. and J. Orgiazzi (2000). "Dysthyroidism and pregnancy: Pay attention to
fetal risk." Revue du Praticien - Medecine Generale 14(498): 878-881.
Chakrabarti, B. (2001). "Radio-iodine (NaI131) therapy in hyperthyroidism." Journal of
the Indian Medical Association 99(11): 642-645.
Dziadosz, M., et al. (2015). "A systematic review of concomitant twin complete molar
gestations at term and recommendations for care." Reproductive Sciences 22: 149A.
Dziadosz, M., et al. (2015). "A systematic review of concomitant twin complete molar
gestations at term and recommendations for care." Ultrasound in Medicine and Biology
41(4): S146.
Fatourechi, M. M. and V. Fatourechi (2014). "An update on subclinical hypothyroidism
and subclinical hyperthyroidism." Expert Review of Endocrinology and Metabolism 9(2):137-151.
Feldt-Rasmussen, U., et al. (2011). "Challenges in interpretation of thyroid function tests
in pregnant women with autoimmune thyroid disease." Journal of Thyroid Research
2011.

Grandi, M., et al. (2008). "Thyroid diseases and pregnancy." Italian Journal of Medicine
2(3): 16-22.
Hackmon, R., et al. (2013). "The safety of methimazole and propylthiouracil in
pregnancy: A systematic review." Obstetrical and Gynecological Survey 68(3): 189-191.
Khan, I., et al. (2017). "Antithyroid drug therapy in pregnancy: a review of guideline
recommendations." Expert Review of Endocrinology and Metabolism 12(4): 269-278.
Sharifi, M., et al. (2014). "Thyrotoxicosis-induced fetal heart failure." Journal of
Investigative Medicine 62(1): 158.
Surks, M. I. (2005). "Letter to the editor [2]." Thyroid 15(1): 32-33.
Tamhane, S. and H. Gharib (2016). "Thyroid nodule update on diagnosis andmanagement." Clinical Diabetes and Endocrinology 2(1).
Vissenberg, R., et al. (2011). "Treatment of (sub) clinical thyroid dysfunction and thyroid
autoimmunity before conception and in early pregnancy: A systematic review." Journalof Reproductive Immunology 90(2): 148-149.
Vissenberg, R., et al. (2012). "Treatment of (sub) clinical thyroid dysfunction and thyroid
autoimmunity before conception and in early pregnancy: A systematic review." Human
Reproduction 27.
Weetman, A. (2016). "Recommended management of thyroid disorders." Prescriber
27(12): 31-38.
Wilson, C. (2011). "Thyroid function: New guidance for the diagnosis and managementof thyroid diseases in pregnancy." Nature Reviews Endocrinology 7(10): 559.
Wilson, C. (2012). "Endocrine disorders in pregnancy: Updated guidelines for the
management of thyroid disorders in pregnancy." Nature Reviews Endocrinology 8(11):624.

Wright, H. V. and D. J. Williams (2013). "Thyrotoxicosis in pregnancy." Fetal andMaternal Medicine Review 24(2): 108-128.
Arata, N., et al. (2016). "Pregnancy outcomes of exposure to methimazole (POEM) study:
Final report." Thyroid 26: A139.
Arata, N., et al. (2014). "Pregnancy outcomes of exposure to methimazole (poem)
study: An interim report." Thyroid 24: A88.
Negro, R., et al. (2010). "Universal screening versus case finding for detection andtreatment of thyroid hormonal dysfunction during pregnancy." Obstetrical and
Gynecological Survey 65(8): 480-482.
Ross, D. S. (2011). "The author replies." New England Journal of Medicine 364(20): 19781979.
Stettner, D., et al. (2013). "Graves' disease and obstetric complications." Ginekologia i
Poloznictwo 29(3): 9-18.
Tabacova, S., et al. (2010). "Adverse developmental events reported to FDA in association
with maternal use of drugs for treatment of hyperthyroidism in pregnancy." BirthDefects Research Part A - Clinical and Molecular Teratology 88(5): 411.
Winther, K. H., et al. (2017). "Is selenium supplementation in autoimmune thyroid
diseases justified?" Current Opinion in Endocrinology, Diabetes and Obesity 24(5): 348355.
(2007). "I Guidelines for Perioperative Evaluation." International Journal of
Atherosclerosis 2(4): 209-250.
Abeillon-Du Payrat, J., et al. (2013). "Predictive value of maternal second generation
TBII assay for neonatal autoimmune hyperthyroidism." European Thyroid Journal 2:
184.
Abraham, P. and S. Acharya (2010). "Current and emerging treatment options for graves'
hyperthyroidism." Therapeutics and Clinical Risk Management 6(1): 29-40.

Ahmed, M. (2014). "Triple phase post partum thyroiditis associated without known risk
factors." Endocrine Reviews 35.
Aleta, L. and C. Cervantes (2010). "Catastrophic antiphospholipid syndrome
occurring postpartum in a young female." Allergy: European Journal of Allergy andClinical Immunology 65: 472.
Andersen, S. L., et al. (2014). "Hyperthyroidism incidence variation in andaround first and subsequent pregnancies: A Danish population-based study." Thyroid 24:
A89-A90.
Andersen, S. L. and P. Laurberg (2016). "Managing hyperthyroidism in pregnancy:
Current perspectives." International Journal of Women's Health 8: 497-504.
Autret-Leca, E. (2010). "Drugs news." Archives de Pediatrie 17(7): 1098-1106.
Barrera, C. R., et al. (2016). "Neonatal Gravesâ€™ diseaseâ€. A medical emergency."
Endocrine Reviews 37(2).
Benjamin, J. S., et al. (2011). "Thyrotoxicosis in the premature infant." Journal of
Investigative Medicine 59(2): 451.
Bham, F. (2017). "Molar pregnancies with a focus on the thyroid." Southern
African Journal of Anaesthesia and Analgesia 23(2): 7-11.
Bihan, H., et al. (2002). "Aplasia cutis congenita and dysmorphic syndrome after
antithyroid therapy during pregnancy." Endocrinologist 12(2): 87-91.
Borremans, C. G. and H. A. Perinetti (2003). "Pregnancy and thyroid diseases." Prensa
Medica Argentina 90(3): 232-243.
Bulmus, N., et al. (2013). "Thyroid diseases in pregnancy: The importance of anamnesis."
Pakistan Journal of Medical Sciences 29(5): 1187-1192.
Cardoso, R., et al. (2015). "Newborns of mothers with graves' disease: Survey of 14 years."
Hormone Research in Paediatrics 84: 561.
Chang, Z. (2017). "Mmind the gap: Flimsy follow-up leads to toxic thyroid." Journal of
General Internal Medicine 32(2): S541-S542.

De La Fuente Vaquero, P., et al. (2015). "Congenitalhy pothyroidism: The result of poor
compliance with the medication of graves basedow disease." Journal of Perinatal
Medicine 43.
Delport, E. F. (2009). "A thyroid-related endocrine emergency in pregnancy." Journal of
Endocrinology, Metabolism and Diabetes of South Africa 14(2): 99-101.
Dhaliwal, A. J. S., et al. (2015). "Hyperemesis gravidarum from suspected graves'disease." Journal of General Internal Medicine 30: S409-S410.
Dodig, D., et al. (2003). "Treatment of Graves' disease with radioiodine (I131)."
Paediatria Croatica, Supplement 47(1): 113-116.
Ducarme, G., et al. (2006). "Pregnancy follow up of Basedow disease, a major role for
fetal

thyroidechographic

scanning."

Revue

du

Praticien-

Gynecologie

etObstetrique(108): 33-37.
Ecker, J. L. and T. J. Musci (2000). "Thyroid function and disease in pregnancy." Current
Problems in Obstetrics, Gynecology and Fertility 23(3): 109-122.
El Baba, K. A. and S. T. Azar (2012). "Thyroid dysfunction in pregnancy." International
Journal of General Medicine 5: 227-230.
Franklyn, J. (2010). "Subclinical thyroid disease." Endocrine Abstracts 21: CM1.1.
Gambardella, V., et al. (2003). "Thyroid diseases in pregnancy." Giornale Italiano di
Ostetricia e Ginecologia 25(9): 361-367.
Gessl, A., et al. (2012). Thyroid disorders. 214: 361-386.
Goyal, M., et al. (2014). "Multiple autoimmune antibody limbic encephalitis: A case in apregnant woman." Neurology 82(10).
Greeve, J. (2003). "Thyroid disorders during pregnancy." Gynakologe 36(11): 965-973.

Harrasser, M., et al. (2013). "Neonatal thyrotoxicosis-potentially life-threatening!" Swiss
Medical Weekly 143: 36S.
Hookham, J., et al. (2017). "Variation in the use of definitive treatment options in the
management of graves’ disease: A UK clinician survey." Postgraduate Medical Journal
93(1098): 198-204.
Hrnčiar, J. and B. Bystrica Sr (2002). "Screening of functional disorders of the thyroid
gland in adults, gravid femels and newborns. Is this sceening effective and how can byrealised now?" Diabetologie Metabolismus Endokrinologie Vyziva 5(4): 230-236.
Hunger-Battefeld, W., et al. (2008). "Thyroid disease in pregnant women with diabetes
mellitus type 1." Geburtshilfe und Frauenheilkunde 68(5): 481-486.
Ilhan, G., et al. (2016). "Evaluation of neutrofil-lymphocyte ratio, platelet-lymphocyte
ratio, red cell distribution width-platelet ratio for the diagnosis of premature ovarian
insufficiency." Journal of the Turkish German Gynecology Association 17: S10.
Jaeggi, E. T. and K. S. Roman (2006). "Maternal autoimmune disease and its impact on
the fetal heart: Management and prognosis." Progress in Pediatric Cardiology 22(1): 8593.
Jafri, R. Z., et al. (2015). "Relationship between maternal graves disease and two
different presentations of congenital hypothyroidism at birth." Endocrine Reviews 36.

Jerónimo, M., et al. (2014). "Transient neonatal hyperthyroidism." Revista Portuguesa
de Endocrinologia, Diabetes e Metabolismo 9(2): 157-161.
Jiang, N., et al. (2015). "Follow-up and evaluation of the pregnancy outcome in womenat reproductive age with graves'hyperthyroidism after 131-iodine treatment." Thyroid
25: A79.
Johnston, N., et al. (2014). "Neonatal thyrotoxicosis in maternal grave's disease: A caseseries and review of the literature." Hormone Research in Paediatrics 82: 460-461.

Johnston, N. F., et al. (2014). "Neonatal thyrotoxicosis: A case series." Irish Journal of
Medical Science 183(4): S141.
Joshi, K. and M. Zacharin (2016). "Hyperthyroidism in an infant of a mother with
autoimmune hypothyroidism with positive TSH receptor antibodies." Hormone Researchin Paediatrics 86: 503.
Joshi, T., et al. (2015). "A peculiar case of molar pregnancy with live fetus associated withthyrotoxicosis." Endocrine Reviews 36.
Kamath, C., et al. (2012). "The role of thyrotrophin receptor antibody assays in Graves'disease." Journal of Thyroid Research 2012.
Kaufman, L. and L. Zimmerman (2003). "Thyrotoxicosis and thyroid storm - A review of
evaluation and management." Primary Care Update for Ob/Gyns 10(1): 29-32.
Khan, M., et al. (2012). "A case of relapse of graves disease presenting as free T3
thyrotoxicosis in the postpartum period." Endocrine Reviews 33(3).
Kim, T. H., et al. (2016). "The association between neonatal birth defects and earlypregnancy use of antithyroid drugs." European Thyroid Journal 5: 67.
Kinjo, S., et al. (2015). "A case of 3 months old Japanese boy with sporadic
congenital noneautoimmune hyperthyroidism." International Journal of PediatricEndocrinology 2015.
Laurberg, P. and S. L. Andersen (2014). "Birth defects after the use of the antithyroid
drugs methimazole and propylthiouracil in early pregnancy are common and may beserious. A danish nationwide study." Endocrine Reviews 35.
Leighton, K. and N. Priddee (2017). "The disappearing haemoglobinopathy trait." British
Journal of Haematology 176: 102.
Levy, M. (2008). "Assessment and management of thyroid disease." Foundation Years
4(6): 237-240.
Lo, J. C., et al. (2012). "The prevalence of antithyroid drug use during pregnancy amongwomen with live births in Northern California." Endocrine Reviews 33(3).
Majeed, M., et al. (2012). "Thyrotoxicosis during pregnancy: Etiologies and outcome."
Thyroid 22: A54.
Marc¸al, L., et al. (2010). "Thyroid function of the newborn offspring of mothers withpositive thyroid antibodies." Hormone Research in Paediatrics 74: 243-244.
McCombe, P., et al. (2014). "Pregnancy outcomes in the alemtuzumab MS clinicaldevelopment program." Multiple Sclerosis 20(1): 436-437.
McCormack, A. I. and D. L. Learoyd (2006). "A guide to thyroid dysfunction." Medicine
Today 7(5): 28-35.
•
McDonough, A. and N. Murphy (2012). "A case of neonatal graves disease." Irish Journalof Medical Science 181: S103.
Mehta, M., et al. (2016). "Methimazole induced acute hepatitis requiring urgent livertransplant evaluation in a pregnant female." Endocrine Reviews 37(2).
Méndez Santos, A., et al. (2016). Pre natal manifestations of hyperthyroidism. 32: S132S133.
Micle, I., et al. (2010). "Diagnostic and treatment difficulties in an infant born to amother with Graves' disease." Hormone Research in Paediatrics 74: 289.
Mirzamoradi, M., et al. (2015). "Evaluation of side effects of ondansetron in pregnancy:
A descriptive case-series study." Tehran University Medical Journal 73(1): 55-59.
Momotani, N. and S. Iwama-Carlson (2015). "Resemblance and diversity of the activityof graves' disease seen in monozygotic female twins over the course of 20 years." Thyroid
25: A63.

Nambiar, V., et al. (2011). "Prevalence and impact of thyroid disorders on maternal
outcome in Asian-Indian pregnant women." Journal of Thyroid Research 2011.

Narwal, P. (2016). "Primary burkitts lymphoma presenting as thyroid mass in
pregnancy." Endocrine Reviews 37(2).
Palacios, S. S., et al. (2012). "Management of subclinical hyperthyroidism." International
Journal of Endocrinology and Metabolism 10(2): 490-496.
Park, K. H. and E. J. Lee (2012). "Recent review on medical treatment of thyroid disease."
Journal of the Korean Medical Association 55(12): 1207-1214.
Patel, D., et al. (2011). "Primary hyperthyroidism and cerebral venous sinus thrombosis- Cause and effect or just a coincidence?" Journal of Investigative Medicine 59(2): 389.
Payrat, J. A. D., et al. (2014). "Predictive value of maternal second generation TBII assay
for neonatal autoimmune hyperthyroidism." Endocrine Reviews 35.
Payrat, J. A. D., et al. (2014). "Predictive value of maternal second generation TBII assay
for neonatal autoimmune hyperthyroidism." Endocrine Reviews 35.
Pushpalatha, K. (2010). "Cardiac diseases in pregnancy - A review." JournalInternational Medical Sciences Academy 23(4): 269-274.
Raue, F. and K. Frank-Raue (2005). "Subclinical hypo- and hyperthyroidism - Diagnostic
and therapeutic implications." Viszeralchirurgie 40(3): 170-173.
Rovet, J. F. and C. Lafoyiannis (2007). "Visual processing in offspring of hyperthyroid
women." Thyroid 17: S51-S52.
Schurmann, L., et al. (2016). "Pregnancy outcomes after fetal exposure to antithyroid
medications or levothyroxine." Early Human Development 101: 73-77.
Shinohara, H., et al. (2015). "Avoidable thiamazole-induced omphalomesenteric duct
remnants: 20-year retrospective study in our hospital." Hormone Research in Paediatrics
84: 548-549.
Smallridge, R. C. (2001). "Postpartum thyroid disease: A model of immunologicdysfunction." Clinical and Applied Immunology Reviews 1(2): 89-103.
Smyth, B. C. (2014). "Sonographic diagnosis of fetal goiter." Journal of Diagnostic
Medical Sonography 30(3): 164-167.
Solymosi, T., et al. (2015). "Percutaneous Ethanol Sclerotherapy of Symptomatic Nodules
Is Effective and Safe in Pregnant Women: A Study of 13 Patients with an Average FollowUp of 6.8 Years." International Journal of Endocrinology 2015.
Stein, S. A. and L. Wartofsky (2010). "Screening for thyroid disease: Defining high-risk
populations." Expert Review of Endocrinology and Metabolism 5(5): 663-671.
Subhadharsini, S. (2016). "Thyroid function in mother and child during pregnancy andneonatal period." Research Journal of Pharmacy and Technology 8(8): 1004-1006.
Thirion, M., et al. (2006). "Thyrotoxicosis." Reanimation 15(6): 497-505.
Titmuss, A., et al. (2015). "Variable neonatal impact of maternal hyperthyroidism inpregnancy." Pediatric Diabetes 16: 144.
Tobar Ponce, R. G. (2017). "Gestational trophoblastic disease: Experience at a specialized
national maternity hospital in El Salvador, “Dr. Raul Arguello Escolan,” January 2003–
december 2012." Journal of Reproductive Medicine 62(5): 534-538.
Truran, P. and S. Aspinall (2014). "Thyrotoxicosis and thyroiditis." Surgery (United
Kingdom) 32(10): 537-542.
Uludaǧ, S., et al. (2003). "Thyroid storm in pregnancy: A case report." Jinekoloji ve
Obstetrik Dergisi 17(2): 118-121.
Wada, R., et al. (2013). "A case of fetal hypothyroidism in pregnancy complicated with
Basedow disease." Prenatal Diagnosis 33: 66.
Wang, Y., et al. (2017). "Influence of screening and intervention of hyperthyroidism on
pregnancy outcome." European Review for Medical and Pharmacological Sciences 21(8):1932-1937.

White, R. D. (2004). "Hyperthyroidism: Current standards of care." Consultant 44(8):1085-1090.
Yoshihara, A., et al. (2014). "Frequency of adverse events of antithyroid drugs
administered during pregnancy." Journal of Thyroid Research 2014.